SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 270 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $4,615,000 | +45.5% | 53,352 | +2.8% | 0.01% | +27.3% |
| Q3 2020 | $3,172,000 | +104.2% | 51,900 | +39.0% | 0.01% | +83.3% |
| Q2 2020 | $1,553,000 | +135.7% | 37,350 | +62.6% | 0.01% | +100.0% |
| Q1 2020 | $659,000 | -2.2% | 22,969 | +146.2% | 0.00% | +50.0% |
| Q4 2019 | $674,000 | -36.2% | 9,329 | +23.8% | 0.00% | -50.0% |
| Q3 2019 | $1,057,000 | -23.2% | 7,536 | +0.3% | 0.00% | -33.3% |
| Q2 2019 | $1,376,000 | +57.6% | 7,515 | +37.0% | 0.01% | +50.0% |
| Q1 2019 | $873,000 | +284.6% | 5,485 | +131.5% | 0.00% | +300.0% |
| Q4 2018 | $227,000 | -29.5% | 2,369 | +3.8% | 0.00% | 0.0% |
| Q3 2018 | $322,000 | -0.6% | 2,282 | +10.4% | 0.00% | -50.0% |
| Q2 2018 | $324,000 | – | 2,067 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |